Author:
Yan Xi,Song Jin-fang,Zhang Liang,Li Xia
Abstract
Abstract
Background
To study the bacteriological characteristics, risk factors, and treatment of multi-drug resistance (MDR) organisms in patients with diabetic foot infection.
Methods
Patients with diabetic foot ulcer admitted to hospital from June 2018 to December 2019 (n = 180) were selected as clinical subjects. Demographic information, routine blood test, wound culture and sensitivity were collected. Risk factors of MDR bacteria were analyzed.
Results
Among 180 patients with diabetic foot ulcer, 146 were positive in bacterial culture, with 84 positive in MDR bacteria. A total of 182 strains were isolated, with 104 strains being multi-drug resistant. Body mass index, glycosylated hemoglobin, fasting blood glucose, triglyceride, course of ulcer, size of ulcer, peripheral neuropathy, peripheral vascular disease, osteomyelitis, peripheral blood leukocyte count, percentage of neutrophils, and previous use of antibiotics were the related factors of infection of MDR bacteria in diabetic foot ulcer patients (P < 0.05). The leukocyte count and neutrophil ratio of MDR-bacilli were lower than those of non MDR-bacilli (P < 0.05).
Conclusion
The risk of MDR bacteria in diabetic foot infection is high. It is necessary to evaluate the risk of multidrug-resistant bacteria by characterizing the course of disease, metabolic control, local ulcer and other aspects in order to formulate an effective treatment plan. The decrease of leukocyte count and neutrophil ratio may be related to damage of the host immune response.
Funder
Laboratoire d'Excellence en Recherche sur le Médicament et l'Innovation Thérapeutique
Jiangsu Provincial Key Research and Development Program
Scientific Research and Technology Development Program of Guangxi
Publisher
Springer Science and Business Media LLC
Subject
General Medicine,Endocrinology, Diabetes and Metabolism
Reference24 articles.
1. BenMoussa M, Khalfallah M, BoutibaBenBoubaker I, Nouira R, Slim A, Jerraya H, et al. Bacteriological and therapeutic profile of diabetic foot infection: a prospective study of 100 patients. La Tunisie Médicale. 2016;94(2):95–101.
2. Tang ZY. The comprehension to the part of diabetic foot infection in Chinese guideline on prevention and management of diabetic foot (2019 edition). World Clini Drugs. 2019;40(9):599–602.
3. Price Bianca L, Lovering Andrew M, Bowling Frank L, Dobson CB. Development of a Novel Collagen Wound Model To Simulate the Activity and Distribution of Antimicrobials in Soft Tissue during Diabetic Foot Infection. Antimicrob Agents Chemother. 2016;60(11):6880–9.
4. Wayne Pa: Clinical and Laboratory Standards Institute: M2-A9[S]. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial disk susceptibility tests 2006
5. Agbi KelechiE, Carvalho Maria, Phan Ha, Tuma Cristiane. Case report: diabetic foot ulcer infection treated with topical compounded medications. Int J Pharm Compd. 2017;21(1):22–7.
Cited by
27 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献